Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Chattanooga, Tennessee Clinical Trials

A listing of Chattanooga, Tennessee clinical trials actively recruiting patient volunteers.

RESULTS

Found (7) clinical trials

Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive HER2-negative Advanced Breast Cancer

The purpose of this study is to assess the efficacy of LEE011, as measured by progression free survival (PFS), in premenopausal women with HR positive, HER2 negative advanced breast cancer

Phase

0.75 miles

Learn More »

A Trial of Linaclotide 290 g in Patients With Irritable Bowel Syndrome With Constipation

12 week treatment period followed by 4-week Randomized Withdrawal (RW) Period.

Phase

9.38 miles

Learn More »

Doctors are Testing an Investigational Product for Preventing Migraines STOP 301 is a new clinical research study that is looking for people who suffer from migraine headaches to test an investigational drug device product. This product is a nasal spray that’s used when you have a migraine attack. (“Investigational” means ...

Phase N/A

9.38 miles

Learn More »

Research Study for Overactive Bladder (OAB)

Phase N/A

9.38 miles

Learn More »

Having trouble going to the bathroom? Don’t be embarrassed — explore your options. Researchers are gathering additional information about the effectiveness of an investigational product for treating irritable bowel syndrome with constipation (IBS-C).

Phase N/A

9.38 miles

Learn More »

An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) for up to 52 Weeks.

This study is designed to evaluate the safety, tolerability, and efficacy of vibegron administered once daily in patients with OAB for up to 52 weeks.

Phase

9.38 miles

Learn More »

A clinical trial designed to evaluate the safety and effectiveness of a new investigational medication under development for adult patients with moderate to-severe atopic dermatitis is currently being conducted. All subjects will receive injections of trial medication every other week for up to 32 weeks. For all trial participants, the ...

Phase N/A

9.38 miles

Learn More »